Concepedia

Kwame Nti-Addae

KN

Statistics

Publications

8

Citations

330

H-Index

8

Active since

2005

Affiliations

University of Kansas(Current)

Vertex Pharmaceuticals (United States)

Kwame Nti-Addae is an author at University of Kansas specializing in pharmacology, drug discovery, and pharmacy.

Publications per year

2005–2017

8

Publications

8

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

Michael P. Clark, Mark W. Ledeboer, Ioana Davies et al. · Journal of Medicinal Chemistry · 2014 · 211 citations · Full text

, , +17

Preparation, characterization and in vivo conversion of new water-soluble sulfenamide prodrugs of carbamazepine

Jeffrey N. Hemenway, Kwame Nti-Addae, Victor R. Guarino et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 27 citations

, , +9

Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2

Luc J. Farmer, Michael P. Clark, Michael J. Boyd et al. · ACS Medicinal Chemistry Letters · 2017 · 25 citations · Full text

, , +16

In vitro Conversion of Model Sulfenamide Prodrugs in the Presence of Small Molecule Thiols

Kwame Nti-Addae, Valentino J. Stella · Journal of Pharmaceutical Sciences · 2010 · 17 citations

, , +5

<sup>1</sup><i>J</i><sub>WSn</sub> as a Solution State Predictor for Tungsten−Tin Solid State Bond Length in Sterically Crowded Tungstenocene Stannyl Complexes

T. Andrew Mobley, R. Gandour, Eric P. Gillis et al. · Organometallics · 2005 · 15 citations

, , +16

1–5 of 8